Research ExplorerPublicationsManagement of patients with autoimmune liver disease during ...

Management of patients with autoimmune liver disease during COVID-19 pandemic

Standard

Management of patients with autoimmune liver disease during COVID-19 pandemic. / Lleo, Ana; Invernizzi, Pietro; Lohse, Ansgar W; Aghemo, Alessio; Carbone, Marco.

In: J HEPATOL, Vol. 73, No. 2, 08.2020, p. 453-455.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Lleo, A, Invernizzi, P, Lohse, AW, Aghemo, A & Carbone, M 2020, 'Management of patients with autoimmune liver disease during COVID-19 pandemic', J HEPATOL, vol. 73, no. 2, pp. 453-455. https://doi.org/10.1016/j.jhep.2020.04.002

APA

Lleo, A., Invernizzi, P., Lohse, A. W., Aghemo, A., & Carbone, M. (2020). Management of patients with autoimmune liver disease during COVID-19 pandemic. J HEPATOL, 73(2), 453-455. https://doi.org/10.1016/j.jhep.2020.04.002

Vancouver

Lleo A, Invernizzi P, Lohse AW, Aghemo A, Carbone M. Management of patients with autoimmune liver disease during COVID-19 pandemic. J HEPATOL. 2020 Aug;73(2):453-455. https://doi.org/10.1016/j.jhep.2020.04.002

Bibtex

@article{475f34d0e2634355999eeb3054c8f2ce,
title = "Management of patients with autoimmune liver disease during COVID-19 pandemic",
keywords = "Betacoronavirus, COVID-19, Coronavirus Infections/prevention & control, Hepatitis, Autoimmune/drug therapy, Humans, Immunocompromised Host, Immunosuppressive Agents/therapeutic use, Infection Control/methods, Liver Cirrhosis/drug therapy, Pandemics/prevention & control, Pneumonia, Viral/prevention & control, SARS-CoV-2, Telemedicine/methods",
author = "Ana Lleo and Pietro Invernizzi and Lohse, {Ansgar W} and Alessio Aghemo and Marco Carbone",
note = "Letter",
year = "2020",
month = aug,
doi = "10.1016/j.jhep.2020.04.002",
language = "English",
volume = "73",
pages = "453--455",
journal = "J HEPATOL",
issn = "0168-8278",
publisher = "Elsevier",
number = "2",

}

RIS

TY - JOUR

T1 - Management of patients with autoimmune liver disease during COVID-19 pandemic

AU - Lleo, Ana

AU - Invernizzi, Pietro

AU - Lohse, Ansgar W

AU - Aghemo, Alessio

AU - Carbone, Marco

N1 - Letter

PY - 2020/8

Y1 - 2020/8

KW - Betacoronavirus

KW - COVID-19

KW - Coronavirus Infections/prevention & control

KW - Hepatitis, Autoimmune/drug therapy

KW - Humans

KW - Immunocompromised Host

KW - Immunosuppressive Agents/therapeutic use

KW - Infection Control/methods

KW - Liver Cirrhosis/drug therapy

KW - Pandemics/prevention & control

KW - Pneumonia, Viral/prevention & control

KW - SARS-CoV-2

KW - Telemedicine/methods

U2 - 10.1016/j.jhep.2020.04.002

DO - 10.1016/j.jhep.2020.04.002

M3 - Other (editorial matter etc.)

C2 - 32283134

VL - 73

SP - 453

EP - 455

JO - J HEPATOL

JF - J HEPATOL

SN - 0168-8278

IS - 2

ER -